Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“Further data is coming, but we know that greater than half of patients (58%) with treatment resistant OCD (trOCD) get a 30% or greater reduction in symptoms. We are publishing, in the future, an open label data, demonstrating that around 20% of patients can get to remission of their OCD symptoms.”
· New Hope, for OCD, Is Insurance Covered*, Thanks to This Very Persuasive Newsletter · substack post

After the coverage news, the author says more data on deep TMS (BrainsWay H7 coil) for treatment-resistant OCD is coming, alongside the present 58% response figure from post-marketing data.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.